UT Health San Antonio Peer-reviewed
Rapamycin Goes Mainstream: UT Health San Antonio Launches Large-Scale Clinical Trial
UT Health San Antonio launches a National Institute on Aging-funded rapamycin trial with 84 older adults—one of the largest longevity-focused clinical studies to date. The shift: from off-label speculation to evidence-based dosing.